News
Healthcare Services Group, Inc. Reports Q1 2022 Results
Healthcare Services Group, Inc. (NASDAQ:HCSG) (the “Company”) reported for the three months ended March 31, 2022 revenue of $426.8 million and net income of $11.3 million, or $0.15 per basic and
Fix Price Group Ltd. : announcement publication of the amended BVI Articles and Cyprus Articles which will be effective as of the Redomiciliation
Navidea Biopharmaceuticals Announces Updated Third-Party Asset Valuation of Tc99m Tilmanocept for Indications in Rheumatoid Arthritis for U.S. and EU Markets
Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) (“Navidea” or the “Company”), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today
Navidea Biopharmaceuticals Announces Positive Preliminary Results of Its Ongoing Phase 2B Study Comparing Tc99m Tilmanocept Imaging with Histopathology of Joints from Patients with Rheumatoid Arthritis
Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) (“Navidea” or the “Company”), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today
NICE Actimize Cloud-Based SURVEIL-X Wins Market Surveillance Category in WATERS 2022 Sell-Side Technology Awards
NICE Actimize, a NICE (NASDAQ: NICE) business, has been chosen as the winner in the Market Surveillance category in the prestigious WATERS Sell-Side Magazine 2022 Technology Awards competition